Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000102

Options or other derivatives

  • Director acquired 13,894 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Director 2024-06-20 Grant or award · Restricted stock units +2,120 2,120 D: show line 1 in the form
Schenkein David P Director 2024-06-20 Grant or award · Stock options (right to buy) +11,774 11,774 D: show line 2 in the form
Loading xslF345X05/wk-form4_1719259772.xml…